PANews December 20 news, according to Globenewswire, the publicly traded biopharmaceutical company Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) announced that, with the approval of its board of directors, the company has purchased $1 million worth of Bitcoin and other cryptocurrencies as part of its strategic efforts. In addition, the company will allow future financing and other transactions to be conducted in cryptocurrency. The company has entrusted all its cryptocurrencies to a fully compliant custodian for safekeeping. The company emphasized that all transactions will fully comply with all relevant financial and audit regulations, ensuring that the processes are secure and legal. The company will continue to monitor market conditions and may increase or decrease its holdings of Bitcoin or other cryptocurrencies as it deems appropriate.
